본문 바로가기
KERD
논문KCI 등재

Treatment of Severe Henoch-Schoenlein Purpura Nephritis in Children

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류소아과학

초록

The overall prognosis of Henoch-Schoenlein purpura (HSP) is favorable, but severe nephritis has a high risk of progression to end stage renal failure. Recent studies emphasize the importance of early treatment in children with severe HSP nephritis, but the treatment of severe HSP nephritis still remains controversial due to the rarity of randomized controlled studies in this field. Nevertheless, several intensive therapies, such as intravenous high- dose methylprednisolone pulse, immunosuppressive/cytotoxic drugs, fibrinolytic therapy, anticoagulants, antiplatelet agent and plasma exchange, have been used in children with severe HSP nephritis. In this review, we focus on the treatment of severe HSP nephritis in children.

Abstract

The overall prognosis of Henoch-Schoenlein purpura (HSP) is favorable, but severe nephritis has a high risk of progression to end stage renal failure. Recent studies emphasize the importance of early treatment in children with severe HSP nephritis, but the treatment of severe HSP nephritis still remains controversial due to the rarity of randomized controlled studies in this field. Nevertheless, several intensive therapies, such as intravenous high- dose methylprednisolone pulse, immunosuppressive/cytotoxic drugs, fibrinolytic therapy, anticoagulants, antiplatelet agent and plasma exchange, have been used in children with severe HSP nephritis. In this review, we focus on the treatment of severe HSP nephritis in children.

참고문헌 (52)

  1. Davin J-C, "Henoch-Schönlein purpura nephritis: an update", Eur J Pediatr, 160, pp.689~695 (2001)
  2. Koskimies O, "Henoch-Schönlein nephritis: long-term prognosis of unselected patients", Arch Dis Child, 56, pp.482~484 (1981)
  3. Goldstein AR, "Long-term follow-up of childhood Henoch-Schönlein nephritis", Lancet, 339, pp.280~282 (1992)
  4. Ronkainen J, "The adult kidney 24 years after childhood Henoch-Schönlein purpura in A retrospective cohort study", Lancet, 360, pp.666~670 (2002)
  5. Chang WL, "Renal manifestations in Henoch- Schönlein purpura: a 10-year clinical study", Pediatr Nephrol, 20, pp.1269~1272 (2005)
  6. Rostoker G, "Schönlein-henoch purpura in children and adults: diagnosis, pathophysiology and management", BioDrugs, 15, pp.99~138 (2001)
  7. Kaku Y, "Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors", Kidney Int, 53, pp.1755~1759 (1998)
  8. Sano H, "Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura", Eur J Pediatr, 161, pp.196~201 (2002)
  9. Shin JI, "Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schönlein purpura", Scand J Rheumatol, 35, pp.56~60 (2006)
  10. Narchi H, "Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review", Arch Dis Child, 90, pp.916~920 (2005)
  11. Niaudet P, "Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch nephritis", Pediatr Nephrol, 12, pp.238~243 (1998)
  12. Wyatt RJ, "Evidence-based assessment of treatment options for children with IgA nephropathies", Pediatr Nephrol, 16, pp.156~167 (2001)
  13. Yoshikawa N, "Pathophysiology and treatment of IgA nephropathy in children", Pediatr Nephrol, 16, pp.446~457 (2001)
  14. Tarshish P, "Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide", Pediatr Nephrol, 19, pp.51~56 (2004)
  15. Rieu P, "Henoch-Schönlein nephritis in children and adults in Morphological features and clinicopathological correlations", Ann Med Interne, 150, pp.151~159 (1999)
  16. Halling SF, "Henoch Schönlein nephritis: clinical findings related to renal function and morphology", Pediatr Nephrol, 20, pp.46~51 (2005)
  17. Ronkainen J, "Outcome of Henoch-Schönlein nephritis with nephrotic-range proteinuria", Clin Nephrol, 60, pp.80~84 (2003)
  18. Ruggenenti P, "Progression, remission, regression of chronic renal diseases", Lancet, 357, pp.1601~1608 (2001)
  19. Shin JI, "Factors affecting histological regression of crescentic Henoch-Schönlein nephritis in children", Pediatr Nephrol, 21, pp.54~59 (2006)
  20. Meadow SR, "Schönlein- Henoch nephritis", Q J Med, 41, pp.241~258 (1972)
  21. Kawasaki Y, "Clinical and pathological features of children with Henoch- Schoenlein purpura nephritis: risk factors associated with poor prognosis", Clin Nephrol, 60, pp.153~160 (2003)
  22. Mir S, "Clinical outcome in children with Henoch-Schönlein nephritis", Pediatr Nephrol, 22, pp.64~70 (2007)
  23. Algoet C, "Renal biopsy 2-9 years after Henoch-Schönlein purpura", Pediatr Nephrol, 18, pp.471~473 (2003)
  24. Flynn JT, "Treatment of Henoch-Schönlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide", Am J Nephrol, 21, pp.128~133 (2001)
  25. Tanaka H, "Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis", Pediatr Nephrol, 18, pp.347~350 (2003)
  26. Oner A, "The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis", Pediatr Nephrol, 9, pp.6~10 (1995)
  27. Iijima K, "Multiple combined therapy for severe Henoch-Schönlein nephritis in children", Pediatr Nephrol, 12, pp.244~248 (1998)
  28. Kawasaki Y, "Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis", Pediatrics, 111, pp.785~789 (2003)
  29. Kawasaki Y, "Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study", Nephrol Dial Transplant, 19, pp.858~864 (2004)
  30. Bergstein J, "Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy", Clin Nephrol, 49, pp.9~14 (1998)
  31. Foster BJ, "Effective therapy for severe Henoch-Schönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathological study", J Pediatr, 136, pp.370~375 (2000)
  32. Singh S, "Severe Henoch-Schönlein nephritis: resolution with azathioprine and steroids", Rheumatol Int, 22, pp.133~137 (2002)
  33. Shin JI, "Can azathioprine and steroids alter the progression of severe Henoch- Schönlein nephritis in children?", Pediatr Nephrol, 20, pp.1087~1092 (2005)
  34. Ronkainen J, "Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis", Pediatr Nephrol, 18, pp.1138~1142 (2003)
  35. Shin JI, "Cyclosporin A therapy for severe Henoch-Schönlein nephritis with nephrotic syndrome", Pediatr Nephrol, 20, pp.1093~1097 (2005)
  36. Shin JI, "Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment", Scand J Rheumatol, 34, pp.392~395 (2005)
  37. Shin JI, "Successful use of cyclosporin A in severe Schönlein-Henoch nephritis resistant to both methylprednisolone pulse and azathioprine", Clin Rheumatol, 25, pp.759~760 (2006)
  38. Shin JI, "Serum IgA", C3 ratio may be a useful marker of disease activity in severe Henoch-Schönlein nephritis, 2005, pp.101, c72~78
  39. Watanabe T, "Pathological improvement of IgA nephropathy and Henoch-Schönlein purpura nephritis with urokinase therapy", Acta Paediatr Jpn, 38, pp.622~628 (1996)
  40. Shin JI, "Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch- Schönlein nephritis in children", J Clin Pathol, 58, pp.1147~1151 (2005)
  41. Hattori M, "Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children", Am J Kidney Dis, 33, pp.427~433 (1999)
  42. Scharer K, "Clinical outcome of Schönlein-Henoch purpura nephritis in children", Pediatr Nephrol, 13, pp.816~823 (1999)
  43. Kawasaki Y, "Plasmapheresis therapy for rapidly progressive Henoch- Schönlein nephritis", Pediatr Nephrol, 19, pp.920~923 (2004)
  44. Wright E, "Childhood vasculitis and plasma exchange", Eur J Pediatr, 166, pp.145~151 (2007)
  45. Wortmann SB, "Refractory severe intestinal vasculitis due to Henoch-Schönlein purpura: successful treatment with plasmapheresis", Acta Paediatr, 95, pp.622~623 (2006)
  46. Wen YK, "Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schönlein purpura treated with plasmapheresis", Pediatr Nephrol, 20, pp.223~225 (2005)
  47. Yamamoto-Shuda Y, "Therapeutic effect of glucocorticoid on experimental crescentic glomerulonephritis", J Lab Clin Med, 134, pp.410~418 (1999)
  48. Coppo R, "Predictors of outcome in Henoch-Schönlein nephritis in children and adults", Am J Kidney Dis, 47, pp.993~1003 (2006)
  49. Chan JC, "Modulating the progression in IgA nephropathy", Nephron Clin Pract, 104, pp.c61~68 (2006)
  50. Camacho Diaz JA, "Long-term effect of angiotensin-converting inhibitors in children with proteinuria", An Esp Pediatr, 55, pp.219~224 (2001)
  51. Dixit MP, "Managing Henoch-Schönlein purpura in children with fish oil and ACE inhibitor therapy", Nephrology, 9, pp.381~386 (2004)
  52. Shin JI, "Methylprednisolone pulse therapy by the Tune-Mendoza protocol in a child with severe Henoch-Schönlein nephritis", Scand J Rheumatol, 35, pp.162~163 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (12건)